Amy Pasternak, PharmD, BCPS 2014-15

Amy Pasternak, PharmD, BCPS

Clinical Translational Pharmaceutical Sciences Post-Doctoral Fellow
University of Michigan Medical Center

Education

  • PGY2 Clinical Pharmacogenetics Pharmacy Resident 2015-2016, St. Jude Children’s Research Hospital, Memphis, TN
  • Teaching and Learning Program 2015-2016, University of Tennessee College of Pharmacy, Memphis, TN
  • PGY1 Pharmacy Resident 2014-2015, Hillcrest Hospital, Mayfield Heights, OH
  • Doctor of Pharmacy 2014, Ohio Nothern University, Ada, OH

Areas of Interest

  • Clinical Pharmacogenetics
  • Oncology

Poster Presentations

  • Pasternak A, Hadair CE, Kornegay N, Cross SJ, Gregornik D, Molinelli A, Hoffman JM, Triplett BM, Relling MV, Crews KR. Impact of initial intravenous tacrolimus dosage on the first tacrolimus concentration in a pediatric hematopoietic stem cell transplant population. ASHP Midyear Meeting. December 2015.
  • Pasternak A, Link NA, Wirick N. Evaluation of a novel dosing strategy for Intravenous Immune Globulin (IVIG) in hospitalized patients in a community hospital. University Health System Consortium Pharmacy Council Meeting. December 2014.
  • Pasternak A, Link NA, Richardson C, Rose PG. An interim analysis of prophylactic conversion to extended-infusion carboplatin effect on the development of hypersensitivity reactions in patients with gynecologic malignancies. ASHP Midyear Meeting. December 2014.

Publications

  • Pasternak AL, Link NA, Richardson C, Rose PG. Effect of Prophylactic Extended-Infusion Carboplatin on Incidence of Hypersensitivity Reactions in Patients with Ovarian, Fallopian Tube, or Peritoneal Carcinomas. Pharmacotherapy. 2016; 36(7): 723-30.
  • Pasternak A, Axtell S. What is the risk of developing diabetes mellitus (DM) while taking a statin? OSHP Bulletin. 2014; 36(6): 4-5.
  • Ginty SE, Pasternak A, Desko L, Amero J, Kisor D. Pharmacogenomic Implications Regarding Second Generation Antipsychotics Clozapine and Risperidone. Pharmacy and Wellness (PAW) Review. 2012 Jan; 3(1): 35-8.
  • Long L, Pasternak A, Hazlet E, Kisor D. The Impact of Pharmacogenomics on Chemotherapeutic Drug Development and Use. PAW Review. 2012, July: 3(3): 70-3.

Honors and Awards

  • Ohio College of Clinical Pharmacy Presentation Style Award, 2014
  • Cleveland Clinic APPE Student Award, 2014

Lecture Presentations

  • Clinical Pharmacogenetics at St. Jude, St. Jude Children’s Research Hospital Nursing Affiliate Conference, 2015
  • CYP3A5 and Tacrolimus, Bone Marrow Transplant Clinical Meeting, St. Jude Children’s Research Hospital, 2015
  • An evaluation of the impact of UGT1A1*60 variant on bilirubin levels, Clinical Pharmacists Meeting, St. Jude Children’s Research Hospital, 2015
  • Pharmacogenomics of CYP2D6 and tamoxifen, Cleveland Clinic, 2015
  • Prophylactic extended infusion carboplatin effect on development of hypersensitivity reactions in patients with gynecologic malignancies, Ohio Pharmacy Residency Conference, 2015
  • Pregnancy and Diabetes, NICU pharmacists training course, Hillcrest Hospital, 2015
  • Update on novel type II diabetes therapies, Hillcrest family medicine physicians, Hillcrest Hospital, 2015
  • Prophylactic conversion to extended-infusion carboplatin effect on the development of hypersensitivity reactions in patients with gynecologic malignancies, Ohio College of Clinical Pharmacy Fall Meeting, 2014